Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nafimidone 在大鼠杏仁核癫痫模型中显示出抗惊厥活性,可用于治疗慢性顽固性癫痫病。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 530 | 现货 | ||
5 mg | ¥ 1,230 | 现货 | ||
10 mg | ¥ 1,830 | 现货 | ||
25 mg | ¥ 3,530 | 现货 | ||
50 mg | ¥ 4,800 | 现货 | ||
100 mg | ¥ 6,830 | 现货 | ||
500 mg | ¥ 13,700 | 现货 |
产品描述 | Nafimidone shows anticonvulsant activity in a rat model of amygdala epilepsy and can be used in the treatment of chronic intractable epilepsy. |
体内活性 | Nafimidone (600 mg/day; 12 patients), was added during 2 weeks in the hospital. Patients were then evaluated weekly for 8 weeks. Eight patients experienced 33-98% improvement in seizure control. Nafimidone had a marked inhibitory effect on the clearance of CBZ and PHT, resulting in higher plasma levels in nine patients.[3] |
分子量 | 236.27 |
分子式 | C15H12N2O |
CAS No. | 64212-22-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (232.79 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 4.2324 mL | 21.1622 mL | 42.3245 mL | 105.8111 mL |
5 mM | 0.8465 mL | 4.2324 mL | 8.4649 mL | 21.1622 mL | |
10 mM | 0.4232 mL | 2.1162 mL | 4.2324 mL | 10.5811 mL | |
20 mM | 0.2116 mL | 1.0581 mL | 2.1162 mL | 5.2906 mL | |
50 mM | 0.0846 mL | 0.4232 mL | 0.8465 mL | 2.1162 mL | |
100 mM | 0.0423 mL | 0.2116 mL | 0.4232 mL | 1.0581 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Nafimidone 64212-22-2 Inhibitor inhibitor inhibit